Safety, Efficacy, and Tolerability of SNA-120 in Subjects With Pruritus Associated With Psoriasis Vulgaris

NCT03322137 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

208

Enrollment

INDUSTRY

Sponsor class

Conditions

Pruritus
Psoriasis Vulgaris

Interventions

DRUG: SNA-120
DRUG: Vehicle

Sponsor

Sienna Biopharmaceuticals